Septerna, Inc. (SEPN) vs Vir Biotechnology, Inc. (VIR)
Septerna, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Septerna, Inc. and Vir Biotechnology, Inc. are of similar size ($1.8B and $1.8B). Septerna, Inc. grew revenue faster over the last twelve months: 13,520.1% against 1,495.9%. Septerna, Inc. has the higher net margin (−24.5% vs −83.0%) and the lower return on invested capital (−189.0% vs −39.1%). Across the 15 metrics below, Septerna, Inc. leads on 9 and Vir Biotechnology, Inc. on 6.
Valuation
Profitability
| Metric | SEPN | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (44.04%) | (92.40%) | 0.00% |
| Net margin | (24.51%) | (83.00%) | 0.00% |
| Free cash flow margin | 118.93% | (67.17%) | 0.00% |
| Return on equity | (6.34%) | (26.08%) | (57.72%) |
| Return on assets | (4.94%) | (20.91%) | (49.22%) |
| Return on invested capital | (189.01%) | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack